US aid freeze claims first victims as oxygen supplies cut off
Pe Kha Lau, a refugee from Myanmar living in a displacement camp in neighbouring Thailand, died four days after she was discharged from a USAID-funded healthcare facility operated by the International Rescue Committee (IRC).
She is thought to be one of the first people to have died as a direct result of Washington's decision to freeze all funding for aid projects for 90 days.
Her family told Reuters that she had frequently been sent to hospital in the last three years as she was dependent on a supply of oxygen, but was sent home after the IRC received a 'stop-work' order in late January.
The organisation operates clinics that cater to roughly 80,000 people in nine refugee camps close to the Myanmar border, but abruptly closed and locked several hospitals to comply with the uncompromising US directive. The agency may be subject to an exemption as it offers lifesaving assistance, but it is not yet clear when a waiver could be issued.
Thai authorities are trying to stem some of the gaps and local people are 'self-mobilising' to offer limited care, but it is already too late for Phe Kha Lau, who is among the first known fatalities of the USAID freeze.
Within days of leaving the IRC hospital, the 71-year-old was struggling to breathe and asked to return to the facility.
'I had to tell her that there is no hospital,' Yin Yin Aye, her 50-year-old daughter, told Reuters in a teary phone call.
Pe Kha Lau's son-in law, Tin Win, added that before the closure, 'whenever she got short of breath, I would carry her right away back to hospital and she would be fine'.
'We are very poor people,' he said. 'I work as a day labourer. We can't afford oxygen at home.'
Pe Kha Lau is not the only one affected. In Umpiem Mai camp in Thailand, which is home to more than 10,000 people who fled the brutal civil war in neighbouring Myanmar, a resident and a health worker told ABC that multiple patients who were reliant on oxygen have now died.
'The medical workers left without even taking the equipment and the patients had to return to their homes, including some who had to be carried out,' said Sulaiman Mawlawi, a camp resident. 'It was a very tragic moment for us.'
There are also reports of refugees giving birth in former school buildings after the hospital closures.
A complicated conflict has been raging in Myanmar since the military seized power four years ago. Almost a third of the population is now reliant on humanitarian aid, while at least 3.5 million have been internally displaced since February 2021. Hundreds of thousands more have fled the country, including into neighbouring Thailand.
Although Asia is not the biggest recipient of US aid – of the $60 billion in foreign assistance that was frozen by the Trump administration, roughly $3.9 billion is spent in South and Central Asia, and $2.1 billion in East Asia and Oceania – the freeze has hit Myanmar especially hard.
America spends around $200 million a year in the country, making it the largest donor, and roughly $40 million goes towards health.
One doctor working inside Myanmar – whose group receives roughly $1.5 million from USAID each year, but who asked not to be named amid concerns it could affect funding in the future – said the sudden halt demonstrates 'a total lack of respect for ill people and life'.
'The stopping and then restarting – instead of planning and then deciding what to stop and what to continue – has of course caused numerous avoidable deaths,' he told the Telegraph, adding that he knows of at least seven NGOs that have stopped some activities.
He said that the full ramifications may take some time to unfold.
'Most of the time you will not see the worst consequences immediately,' the doctor said by email. 'If you stop TB or AIDS treatment it can take months, a year before the patient dies. However, the patient's bacteria or virus might have developed resistance which will make it much more difficult to treat when you re-start.'
Another medic in central Myanmar, a region hard hit by the conflict, said his team have had to pause services because they do not have reserve funds to stem gaps from the USAID freeze. His group receives close to $2 million a year.
'We will lose that amount to save the lives of the people – so it is frustrating for us,' he told the Telegraph, also asking to remain anonymous. 'Without the US, we don't have funds to continue a lot of our work.'
Tom Kean, a Myanmar researcher at the Crisis Group thinktank, said that although 'life-saving humanitarian assistance' is supposed to be exempt – as well as efforts to tackle diseases such as malaria, newborn deaths and malnutrition – many of these programmes are still waiting for confirmation they can continue.
'Without confirmation, they risk incurring expenses that USAID then refuses to reimburse – a risk they literally can't afford to take,' he said. 'It's also very unclear at this stage whether the programmes that have definitely been suspended pending review – those that are not providing 'life-saving humanitarian assistance' – will be allowed to resume or cancelled.'
He added that USAID's partners, who implement programmes on the ground, and their beneficiaries have been left in a 'terrible position' as the chaos continues.
'There's nothing wrong with a review of aid spending – this happens regularly. But existing programming should have been allowed to continue while the review is carried out.'
The Telegraph has contacted the US Embassy in Bangkok for comment.
The IRC has not yet responded to the Telegraph, but told Reuters: 'To hear of this loss of life is devastating and we offer our condolences to the family and friends of Pe Kha Lau.'
Protect yourself and your family by learning more about Global Health Security
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
US pediatric group breaks with federal policy, recommends COVID-19 vaccines for young children
(Reuters) -The American Academy of Pediatrics on Tuesday recommended that all young children get vaccinated against COVID-19, differing from federal policy that no longer recommends routine COVID vaccination for healthy children. The U.S. pediatric group, in its latest policy document, said all young children aged 6-23 months should receive a COVID-19 vaccine regardless of previous doses or SARS-CoV-2 infection, and recommended vaccination for older children in certain risk groups. The U.S. Centers for Disease Control and Prevention said in May COVID-19 vaccines are now an option for healthy children when parents and doctors agree that it is needed. Prior to the new guidance, the agency routinely recommended updated COVID vaccines for everyone aged six months and older, in line with the advice of its panel of outside experts. "Shared clinical decision-making (involving parents and doctors) can be difficult to implement because it lacks clear guidance and does not emphasize the importance of vaccinating people at high risk of severe disease," the AAP said in a statement. In early July, the AAP and other major medical groups sued Health and Human Services Secretary Robert F. Kennedy Jr. for unilaterally removing routine vaccination recommendations. The rate of COVID-19 hospitalization for children under 2 years is the highest among pediatric age groups, and for children aged 6-23 months, it is comparable to people aged 50-64 years, the group said on Tuesday, citing CDC data. The U.S. Department of Health and Human Services earlier this month said it is reinstating a federal task force for safer childhood vaccines after a 27-year hiatus.


Miami Herald
10 hours ago
- Miami Herald
Traveler from Cuba stopped at airport after shocking find in bottle
U.S. Customs and Border Protection (CBP) reported an incident involving a traveler arriving from Cuba at Houston's George Bush Intercontinental Airport. The federal agency used the case to issue a warning on Friday on social media after seizing a bottle containing what it described as a 'biological substance' whose importation into the country is regulated. After an inspection by CBP agricultural specialists, the bottle was ultimately confiscated, according to Jud Murdock, CBP's Director of Field Operations in Houston. Read more: Customs issues strong warning: Travelers in Florida could lose these 'privileges' Murdock's post explained that the bottle seized from the traveler arriving from Cuba contained scorpion venom. Although the passenger said the venom was intended for medical purposes, Murdock stated in an X post that they did not have the 'documentation to import the biological substance.' CBP and associated government agencies regulate the importation of biological materials through airports because they 'may pose a threat to agriculture, public health and natural resources.' 'All biological materials imported into the United States must be documented, labeled, packaged, marked and declared in accordance with applicable international, federal and state regulations,' CBP stated. Failure to comply with these regulations can result in delays in importation, civil or criminal penalties, and/or the seizure of the biological materials, CBP said. Biological materials can be declared verbally to Customs, via the Mobile Passport Control app, at a self-service kiosk (such as Global Entry or Automated Passport Control), or by using CBP Form 6059B. 'Please leave the home remedies at home,' the agency warned in another X post about the incident. In Cuba, scientists have promoted the use of blue scorpion (Rhopalurus junceus) venom, a species endemic to the island, as a remedy for inflammation and pain, which may also slow tumor growth in some cancer patients. A Reuters report states that the Cuban state-owned pharmaceutical company Labiofam has been using scorpion venom since 2011 to produce the homeopathic medicine Vidatox. The product is listed in Cuba's clinical trials registry, and Labiofam recommends it as a supplementary treatment that should not replace conventional medicine. Although Vidatox has gained some popularity over the years and Cuba sells it in several countries, foreign scientists argue that more research is needed to support its claimed effects on cancer, according to Reuters.
Yahoo
13 hours ago
- Yahoo
Vaccine panel fired by Kennedy had lowest rate of financial conflicts since 2000, study shows
By Nancy Lapid (Reuters) -Conflicts of interest on the U.S. Centers for Disease Control and Prevention's vaccine advisory committee were at historic lows around the time when Health Secretary Robert F. Kennedy Jr. fired all 17 members in June, new data published in a medical journal on Monday showed. Kennedy had said, based on findings from a 2007 report, that the Advisory Committee on Immunization Practices (ACIP) was rife with conflicts. The new study published in JAMA found that between 2000 and 2024, ACIP's annual reported conflict of interest rate declined from 42.8% to 5%. ACIP advises on which groups of people should take each vaccine approved by the U.S. Food and Drug Administration, and when they should be administered. Conflict of interest rates on the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC), which advises the agency on whether to approve vaccines, have remained below 4% since 2010, including 10 years when it was 0%, the researchers also found. The most frequently reported conflict of interest was funding for research, which is generally considered less concerning than financial ties associated with personal income, the researchers said. The prevalence of conflicts related to personal income – such as from consulting, royalties, or stock ownership – had been below 1% for both committees since 2016. 'In the past, there have been high levels of reported conflicts on influential vaccine committees, but there has been substantial progress since the early 2000s,' study leader Genevieve Kanter of the Schaeffer Center at the University of Southern California said in a statement. 'Secretary Kennedy is right that conflict of interest is an important issue, but he is wrong that it is present at substantial levels on (U.S. Department of Health and Human Services) vaccine advisory committees,' co-author Peter Lurie, president of the Center for Science in the Public Interest and former FDA associate commissioner, said in a statement. Responding to the study, Department of Health and Human Services press secretary Emily Hilliard said, "Secretary Kennedy is committed to eliminating both real and perceived conflicts to strengthen confidence in public health decisions." Earlier this year, the agency launched its ACIP Conflicts of Interest Disclosures tool, she noted. Solve the daily Crossword